A presentation from the NCCN 12th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ held in Hollywood, Florida, on March 16, 2007

Presenter

Joseph O. Moore, MD
Duke Comprehensive Cancer Center
Durham, North Carolina

Faculty Disclosure Statement

Dr. Moore has disclosed that he has financial interests, arrangements, or affiliations with the manufacturer of products and devices to be discussed in his presentation or who may financially support the educational activity. He has received payment for serving as a speaker for Amgen Inc., Genentech, Inc., and Novartis Pharmaceuticals Corporation. Dr. Moore has indicated that his presentation will not include discussion of investigational or unlabeled uses of a product.

Program Overview

This presentation will explore the latest advances in the management of patients with chronic myelogenous leukemia. Primary conventional dose therapy, second-line therapy, and patient selection for transplant will be outlined.

Educational Objective

Following this activity, participants should be able to discuss how advances in treatments will improve outcomes for patients with chronic myelogenous leukemia.

Intended Audience

This educational activity is designed to meet the needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.

Activity Instructions

Continuing education credit will be awarded to participants who listen to the presentation and complete the evaluation. Participants should review the learning objective and faculty disclosure statement prior to listening to a presentation in its entirety. You must be connected to the Internet in order to review and complete the evaluation form. A statement of credit will be electronically generated once you complete the evaluation form. To receive credit, this activity must be completed no later than May 24, 2008. There is no fee for participating in this activity.

Download Podcast

Listen to MP3

Podcast Evaluation

Accreditation Information

Physicians

The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

NCCN designates this educational activity for a maximum of 1.5 AMA PRA Category
1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses

This activity is approved for 1.5 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

Release date: May 24, 2007
Expiration date: May 24, 2008

Commercial Support

Distribution supported by an educational grant from Bristol-Myers Squibb Company

Mark A A Size

Find information for: